Chemoinformaics analysis of Phosphatidylcholine
| Molecular Weight | 677.945 | nRot | 34 |
| Heavy Atom Molecular Weight | 605.369 | nRig | 3 |
| Exact Molecular Weight | 677.5 | nRing | 0 |
| Solubility: LogS | -3.401 | nHRing | 0 |
| Solubility: LogP | 7.406 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 118 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 119.275 |
| nHD | 0 | BPOL | 92.7669 |
| QED | 0.029 |
| Synth | 3.891 |
| Natural Product Likeliness | 0.493 |
| NR-PPAR-gamma | 0.436 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.033 |
| Pgp-sub | 0.998 |
| HIA | 0.908 |
| CACO-2 | -5.274 |
| MDCK | 0.0000156 |
| BBB | 0.001 |
| PPB | 0.97718 |
| VDSS | 0.243 |
| FU | 0.0248841 |
| CYP1A2-inh | 0.031 |
| CYP1A2-sub | 0.675 |
| CYP2c19-inh | 0.386 |
| CYP2c19-sub | 0.115 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.985 |
| CYP2d6-inh | 0.072 |
| CYP2d6-sub | 0.409 |
| CYP3a4-inh | 0.715 |
| CYP3a4-sub | 0.016 |
| CL | 3.165 |
| T12 | 0.762 |
| hERG | 0.877 |
| Ames | 0.116 |
| ROA | 0.052 |
| SkinSen | 0.95 |
| Carcinogencity | 0.128 |
| EI | 0.014 |
| Respiratory | 0.512 |
| NR-Aromatase | 0.668 |
| Antiviral | No |
| Prediction | 0.586859 |